Our Blog

How can generative AI be used in cybersecurity? Practical uses in pentesting/AppSec, compliance automation, key tools, risks (phishing, prompt injection), and best practices.

Discover what we learned analyzing 50 biotech companies in 2025 — including critical cybersecurity risks like insecure APIs, leaked credentials, and misconfigured environments. This report highlights real-world threats to genomic data, HIPAA/GDPR compliance, and patient trust, with practical steps for biotech and healthtech teams to improve their security posture.

As biotech and healthtech companies scale across borders, they face a central challenge: how to lawfully collect, store, and use ...

Biotech companies are under pressure to prove strong data security and compliance. This practical ISO 27001 guide and checklist outlines what biotech firms need to know in 2025 — from protecting IP and clinical data to choosing the right auditor and reducing risk.

Navigating MDR cybersecurity compliance under the EU’s new medical and in vitro diagnostic regulations can be complex. This in-depth guide helps device manufacturers understand and implement the cybersecurity requirements of EU MDR (2017/745) and IVDR (2017/746) — from secure-by-design principles to post-market surveillance and CE certification. If you're building or selling connected medical devices or software in Europe, this is essential reading.

When Regeneron announced its $256 million acquisition of 23andMe, most headlines focused on drug discovery potential. But beneath the surface lies a deeper concern: the fate of 15 million genetic profiles. At Sekurno, we unpack the post-acquisition security risks, Regeneron’s breach history, and why compliance alone isn’t enough to protect the world’s most personal data—your DNA.